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changes between subchondral bone phenotypes. These data suggest
that osteoimmunological interactions between these populations might
be involved in OA bone remodeling.
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CHARACTERIZATION OF FOLATE RECEPTOR BETA EXPRESSION ON
CELLS OF BONE ORIGIN
H.N. Daghestani, Z. Huang, V.B. Kraus. Duke Univ., Durham, NC, USA
Purpose: Despite being one of themost common types of arthritis and a
leading cause of disability worldwide, effective therapeutics for osteo-
arthritis (OA) are still unavailable. We recently showed in a cross-sec-
tional pilot study (25 patients, 50 knees) the localization of folate
receptor beta (FR-b) positive macrophages in joints using 99mTcEC20
imaging. The presence of activated macrophages, localized to the
synovium, was associated with knee OA clinical symptoms; the pres-
ence of activated macrophages localized to the knee joint capsule of the
tibiofemoral joint was associated with severity of knee joint space
narrowing. However, 16% of the patients revealed positive 99mTc-EC20
uptake in the subchondral bone of osteoarthritic knees. The potential
for expression of this receptor on cells of the bone has not been pre-
viously evaluated but is possible based on the knowledge that osteo-
clasts are multinucleated cells that derive from hematopoietic
progenitors in the bone marrow, which also give rise to monocytes in
peripheral blood, and to various types of tissue macrophages2. To better
understand the cell types identiﬁed and targeted by folate conjugates
and thereby assist with interpretation of 99mTc-EC20 images in
patients with arthritis, the goal of this study was to evaluate the
expression of folate receptors on cells of bone origin under resting and
activated conditions.
Methods: The quantitation of FR-b, macrophage markers (CD14, CD163,
CD64, CD80, TGF-B, and iNOS), osteoclast markers (cathepsin K and
calcitonin receptor), and osteoblast markers (collagen type I and
osteocalcin) mRNA was evaluated by reverse transcriptase polymerase
chain reaction (RT-PCR) on human macrophage, osteoclast, and osteo-
blast cell lines. The expression of these proteins was also evaluated by
multi-color confocal ﬂuorescence microscopy using Alexa Fluor® 568,
Alexa Fluor® 647, and ﬂuorescein isothiocyanate conjugates.
Results: Gene expression analysis indicated the presence of low levels
of FR-b in resting macrophages and precursor osteoclasts, and the
absence of expression in osteoblasts, in comparison to the house-
keeping genes ACTB and RPL37A. FR-b expression decreased 3.6 fold
after osteoclast differentiation and maturation. Cell staining indicated
similar results, suggesting that FR-b is primarily expressed on synovial
macrophages.
Conclusions: These results suggest that synovial macrophages are the
primary cell type expressing FR-b in the synovium of patients with OA.
It is possible that targeting and inhibiting FR-bþ macrophages may be
used to reduce the inﬂammation observed in OA.
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USING EPIPHYSEAL VOLUME TO SCREEN FOR GENES INFLUENCING
OSTEOPHYTE FORMATION IN MUTAGENIZED MICE
T.L. Vincent y, A. Freidin y, P. Das Neves Borges y, A. Blease z, P. Potter z.
y The Kennedy Inst., Oxford, United Kingdom; zMRC Harwell, Oxfordshire,
United Kingdom
Purpose: Genetic modiﬁcation in mice is a powerful tool for inves-
tigating pathways that inﬂuence the course of experimental osteo-
arthritis. For the most part these involve testing candidate pathways
that have been identiﬁed from in vitro studies. The majority of pub-
lished studies focus on the inﬂuence of such pathways on degeneration
of the articular cartilage. Changes occurring in other tissues of the joint
such as the bone, synovium and ligaments are relatively neglected.
Mutagenesis programmes, in which random mutations are induced in
populations of mice, provide an opportunity to discover novel genes in
disease in an unbiased fashion. Here we report our preliminary data in
which we use epiphyseal volume measurements, an indicator of
osteophyte volume, after induction of OA, to screen for aberrant bone
responses in mutagenized mice.Methods: We are analyzing mice from the Harwell ENU mutagenesis
programme, a large-scale phenotype-driven screen. Such screens
make no a priori assumptions on the genetic basis of a phenotype and
hence act as a discovery tool for the identiﬁcation of new genes and
pathways associated with a particular phenotype. Mice bearing ran-
dom point mutations throughout their genome are analysed pheno-
typically and, once conﬁrmed, outliers undergo SNP mapping and
whole genome sequencing to identify the underlying mutation. In
addition to the modiﬁer screen, cohorts of the same mice are aged to
18 months as part of the Harwell Ageing screen. This provides the
ability to screen the same mutations in induced as well as sponta-
neous (age-related) OA.
To date, 50 ten week old male mice from this on-going mutagenesis
programme have undergone surgical destabilistion of the medial
meniscus (DMM). At 4 weeks post surgery joints were scanned by
microCT using CTan (2012-13 Bruker microCT) imaging software, and
epiphyseal volume calculated by manually outlining the tibial epi-
physis from the right (operated) and left (non-operated) knees (as
described by us recently, Das Neves Borges et al, 2014). Selected joints
were sent for serial sectioning and histological scoring to validate the
bone phenotype and to look for associated joint changes in other
tissues.
Results: We observed that at 4 weeks post DMM the majority of mice
gained epiphyseal volume in the destabilized joint compared with the
non-operated joint. By comparing the epiphyseal volumes in operated
versus non-operated knees of individual mice, two pedigrees immedi-
ately stood out as outliers. One of these had higher non-operated epi-
physeal volume but had an appropriate increase in volume upon joint
destabilization. The second outlier had normal epiphyseal volume in
the non-operated joint but lost substantial volume after joint destabi-
lisation. 3 mice that were related to the latter pedigree showed a
modest reduction in epiphyseal volume following DMM. Tissue samples
from outlier mice have been sent for mapping and the lines have been
re-derived for further in vivo studies.
Conclusions: Mutagenesis studies combined with rapid validated
screening tests provide a realistic approach for discovering novel genes
in OA pathogenesis.
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OSTEOSCLEROTIC BONE PHENOTYPE IS STABLY IMPRINTED IN
SUBCHONDRAL MESENCHYMAL STROMAL CELLS IN HIP AND KNEE
OSTEOARTHRITIS
D. Bianco y, T. Cengic y,z, G.I. Pagenstert y, C. Forster-Horvath y,
V. Valderrabano y, T. Hügle y, J. Geurts y. yUniv. Hosp. Basel, Osteoarthritis
Res. Ctr. Basel, Basel, Switzerland; zUniv. of Zagreb, Zagreb, Croatia
Purpose: The subchondral bone tissue plays a key role in the onset and
progression of osteoarthritis (OA), since alterations of the bony bed
precede cartilage lesions. Subchondral bone sclerosis in OA is char-
acterized by an increase of bone material that is hypomineralized,
caused by a dysregulated osteoblast phenotype. This increased bone
anabolism suggests the involvement of mesenchymal stromal cell
(MSC) recruitment and their differentiation into osteoblasts. In this
study, we investigated whether the properties of these osteoproge-
nitors have changed in nonsclerotic and sclerotic OA subchondral
bone.
Methods: Five knee tibial plateaus and four femoral heads were
obtained from patients (mean age 65) undergoing total knee and hip
arthroplasty, respectively. Subchondral bone tissues (± 1.5 g wet
weight) from nonsclerotic and sclerotic regions were digested in aMEM
containing 0.6 mg/ml collagenase IA for three hours and nucleated bone
marrow cells were isolated by plastic adherence. First passage cells
were seeded at colony forming densities and cultured for 2 weeks in
control or osteogenic medium. Osteogenic (CFU-O) and total number of
colonies (CFU-f) were counted after alkaline phosphatase (ALP) and
methylene blue staining, respectively. Conﬂuent cultures were sub-
jected to osteogenic differentiation for three weeks and evaluated using
ALP staining, quantitative ALP assays and qualitative analysis of min-
eralization by Alizarin Red staining.
Results: MSC clonogenicity, assessed by CFU-f counts, was 20.1±2.2%
in nonsclerotic and 17.0±3.5% in the sclerotic subchondral tissue,
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genic potential of MSCs from knee joints, expressed as CFU-O efﬁ-
ciency, was very high without signiﬁcant differences between
nonsclerotic (91.8±1.6%) and sclerotic (91.6±3.4%) tissues. For the hip
we also did not ﬁnd signiﬁcant statistical differences comparing
nonsclerotic (69.8±5.6%) and sclerotic (56.0±19.1%) tissues; but their
osteogenic potential was signiﬁcantly reduced (p<0.05) compared
with MSCs from knee joints. Efﬁcient induction of osteogenic differ-
entiation was corroborated by quantitative assays, demonstrating a
5.4- and 4.2-fold increase of ALP activity in nonsclerotic and sclerotic
MSCs, respectively. Interestingly, in ﬁve out of six donors signiﬁcant
differences were found in ALP activity between nonsclerotic and
sclerotic MSCs. Unexpectedly, in vitro mineralization was absent in
nonsclerotic MSCs of all donors. Sclerotic MSCs demonstrated a
blunted mineralization phenotype, evidenced by absence of Alizarin
Red staining in six donors, mild staining in two donors and strong
mineralization in a single donor.
Conclusions: Our ﬁndings suggest that MSCs derived from OA sub-
chondral tissues adopt an aberrant osteoblastic phenotype upon
osteogenic induction. Differential ALP activity and hypomineralization,
characteristics of OA subchondral bone sclerosis, appear stably
imprinted in tissue-resident osteoprogenitors.Cartilage Biology & Biochemistry
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LOSS OF ANP32A INCREASES SEVERITY OF OSTEOARTHRITIS IN
DIFFERENT MOUSE MODELS
F.M. Cornelis, L. Storms, R.J. Lories. KU Leuven, Leuven, Belgium
Purpose: Osteoarthritis is one of the most common chronic muscu-
loskeletal disorders and a cause of serious morbidity and disable-
ment, particularly in the elderly population. The disease can be
conﬁned to one or more joints, but can also be generalized. Pro-
gressive damage to the articular cartilage and bone leads to pain and
loss of joint function. The current therapeutic strategies are limited:
changes in lifestyle and appropriate exercise and use of painkillers
and anti-inﬂammatory medication. Eventually, in many cases, joint
replacement surgery may be required, especially for the larger joints.
The development of osteoarthritis is very complex, due to the acti-
vation of several signaling pathways in the different tissues com-
posing the joint, and is inﬂuenced by both genetic and acquired or
environmental risk factors. We have recently described an association
between polymorphisms in the ANP32a gene and osteoarthritis.
Anp32a (acidic leucine-rich nuclear phosphoprotein 32 family
member a) functions as a tumor suppressor gene and a regulator of
gene transcription. It is also implicated in the stabilization of RNA,
intracellular transport and apoptosis. Moreover, Anp32a associates
with Axin-1 and Phosphatase 2A, molecules that exert a regulating
role in the Wingless-type signaling (Wnt) pathway. Wnts are key
players in embryonic development with effects on cell differentiation,
proliferation and migration. Wnt signaling is also critical for the
induction as well as the maintenance of skeletal tissues, is involved in
the very early stages of joint formation and appears to be re-activated
during adult joint homeostasis.
Methods: Different established mouse models for osteoarthritis (OA)
were introduced in Anp32a knockout mice. These include papain-
induced arthritis, which is characterized by direct cartilage proteogly-
can loss, and DMM-induced arthritis, which is a surgical model of
meniscus destabilization, leading to uni-compartimental arthritis,
caused bymild instability of the knee. Severe instability of the knee was
caused by affecting collagen-rich structures in a collagenase-induced
arthritis model. A last model mimics Il1-driven inﬂammatory arthritis.
A transcriptome analysis to study molecular changes in the articular
cartilage of mice deﬁcient in Anp32a was also performed. RNA was
isolated from articular cartilage of the tibial plateau of knees and used in
a microarray study to compare gene expression with cartilage from
normal wildtype C57Bl/6 mice. Four C57Bl/6 wild type (WT) and 4Anp32a-/- mice RNA samples were analyzed on Affymetrix Mouse 430
2.0 chips.
Results: In the DMM- and collagenase-induced OA models, absence
of Anp32a resulted in increased cartilage damage, contributing to
the development of osteoarthritis. In the papain-induced OA model,
a trend for increased cartilage damage was observed in the
Anp32a-/- mice. Induction of the mBSA OA model in the Anp32a-/-
mice lead to increased inﬂammation and bone erosion. Several
genes related to chondrogenesis, to the development of OA and to
the Wnt signaling pathway were identiﬁed in our transcriptome
analysis.
Conclusions: Our analysis provides evidence for an important role for
Anp32a in joint homeostasis and highlights the complex biology ofWnt
signaling in the joint.
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HIF1a/b-CATENIN COMPLEX IS A TRANSCRIPTIONAL REPRESSOR OF
MMP13
W. Bouaziz y, J. Sigaux y, D. Modrowski y, C. Marty y, S. Provot y,
H.-K. Ea y,z, M. Cohen-Solal y,z, E. Hay y,z. y INSERM U1132, Paris, France;
zUniv. Paris-Diderot, Paris, France
Purpose: Activation of Wnt/b-catenin pathway triggers chondrocyte
catabolism andMMP13 activation that contribute to osteoarthritis (OA).
The mechanism of down-regulation of Wnt/b-catenin pathway in car-
tilage homeostasis is unknown. Because chondrocytes are in a hypoxic
environment that is lost in OA, we speculated that Hypoxia Inducible
Factor 1a (HIF1a) inhibits Wnt signaling and chondrocyte catabolism.
Therefore, we here investigated the interaction of b-catenin/TCF4 and
the molecular regulation of Mmp-13 in articular chondrocytes and in
OA mice
Methods: Primary murine chondrocytes from WT and DHIF1a
were cultured with Wnt3a in normoxic (21% O2) and hypoxic (1%
O2) conditions and analyzed the expression of catabolic markers.
The binding of TCF4 to Mmp-13 regulatory regions was assessed
in Chip assay in both conditions. To determine the impact of the
interaction of Wnt and HIF1a in healthy cartilage and in OA,
DHIF1achon and ﬂ/ﬂ HIF1a underwent DMM and received artic-
ular injection of PKF 118-310, an inhibitor of b-catenin and TCF4
interaction.
Results: Hypoxia prevented the increase in Mmp-13 and the decrease
in Col2 and ACAN expression induced by Wnt. Blocking HIF1a by siRNA
or cre-recombinase enhanced the expression of Mmp-13, but not Col2
expression suggesting that HIF1a regulated catabolic rather than
anabolic genes. In hypoxic chondrocytes, Chip assay revealed that
HIF1a lowered b-catenin/TCF4 transcriptional activity and the
expression of Mmp13. Indeed, HIF1a interacted with b-catenin which
displaced TCF4 from Mmp13 regulatory sequences. Moreover, DMM
resulted in decreased HIF1a expression in articular cartilage of control
mice. Furthermore, cartilage lesions were higher in DHIF1achon mice
submitted to DMM along with higher expression of b-catenin and
Mmp13. Local administration of PKF 118-310 in DHIF1achon reduced
Mmp13 expression and prevented cartilage lesions. These results
showed that HIF1a limited cartilage breakdown by blocking the
binding of b-catenin to TCF4 subsequently leading to a lower Mmp-13
activation.
Conclusions: We show here that HIF1a forms a complex with b-
catenin that acts as a negative regulator of Wnt signaling and
Mmp13 transcription. Therefore, targeting the interaction is a new
approach to reduce chondrocyte catabolism and prevent from
osteoarthritis.
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CARTILAGE PERMEABILITY ASSESSMENT BASED ON PROTEOMIC
ANALYSIS OF PLASMA PROTEIN PENETRATION
M.-F. Hsueh y, A. Khabut z, S. Kjellstr€om x, P. €Onnerfjord z, V.B. Kraus 4.
yDept. of Pathlogy, Duke Univ., Durham, NC, USA; zDept. of Clinical Sci.,
Lund Univ., Lund, Sweden; xDept. of Biochemistry and Structural Biology,
Lund Univ., Lund, Sweden; kDept. of Med., Duke Univ., Durham, NC, USA
